Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT06091566Not ApplicableRecruiting

Safety and Performance of UCon Bar Electrode for the Treatment of Overactive Bladder (OAB) and Bowel Dysfunction (BD)

Role: lead

NCT05864807Not ApplicableCompleted

UCon Treatment of the Symptoms of Faecal Incontinence (FI)

Role: lead

NCT05874375Not ApplicableRecruiting

UCon Treatment of Overactive Bladder (OAB) in Males

Role: lead

NCT06754189Not ApplicableRecruiting

Safety and Performance of UCon Patch Electrode

Role: lead

NCT05368246Not ApplicableCompleted

Safety and Performance of UCon for the Treatment of the Symptoms of Overactive Bladder (OAB) / Bowel Dysfunction (BD)

Role: lead

NCT05804552Not ApplicableCompleted

The Effect of Dorsal Genital Nerve Stimulation on Opening Urethral Pressure

Role: collaborator

All 6 trials loaded